Human Immunology Biosciences

Human Immunology Biosciences Employees

13 people indexed:

Human Immunology Biosciences Company Information

Human Immunology Biosciences is a biotechnology company located at 6000 Shoreline Court, Suite 304, South San Francisco, CA 94080. The company specializes in leveraging human genetic and immunological insights to develop targeted therapies for severe immune-mediated diseases. It has several clinical-stage programs and a robust pipeline addressing a range of diseases across the immune landscape. Human Immunology Biosciences recently announced a $95 million Series B financing to further advance these therapies. The company has received FDA Orphan Drug Designation for Felzartamab for the treatment of Antibody-Mediated Rejection in kidney transplant recipients and Breakthrough Therapy Designation for the treatment of Primary Membranous Nephropathy. It holds exclusive worldwide rights to Felzartamab, excluding Greater China. Additionally, the company is developing Izastobart/HIB210, an anti-C5aR1 antibody aimed at treating complement-mediated diseases, holding exclusive rights worldwide except in Greater China and South Korea.

report flag Report inaccurate information

No searches found for this company.

report flag Report inaccurate information

Companies similar to Human Immunology Biosciences

Endpoint Health, headquartered in Palo Alto, CA, specializes in Precision Immunology, focusing on developing next-generation precision medicines for immune-mediated inflammatory diseases.

People indexed

3T Biosciences develops next-generation therapies for solid tumors and immune-mediated diseases using proprietary technology and machine learning, based in South San Francisco.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free